title: retSDR1, a short-chain retinol dehydrogenase/reductase, is retinoic acid-inducible and frequently deleted in human neuroblastoma cell lines.
abstract: Vitamin A is required for a number of developmental processes and for the homeostatic maintenance of several adult differentiated tissues and organs. In human neuroblastoma (NB) cells as well as some other tumor types, pharmacological doses of retinoids are able to control growth and induce differentiation in vitro and in vivo. In a search for new genes that are regulated by retinoids and that contribute to the biological effects retinoids have on NB cells, we have isolated five differentially expressed transcripts. Here we report on the characterization of one of them (DD83.1) in NB cell lines. DD83.1 is identical to the human retSDR1, a short chain dehydrogenase/reductase that is thought to regenerate retinol from retinal in the visual cycle. Its expression is strongly, but differently, regulated by retinoids in NB cell lines, and it is widely expressed in human tissues, which suggests that it is involved in a more general retinol metabolic pathway. Both the retinoic acid-dependent and the exogenous expression of retSDR1 in SK-N-AS cells induce the accumulation of retinyl esters, which indicates that it is involved in generating storage forms of retinol in tissues exposed to physiological retinol concentrations. We also show that the human retSDR1 gene, which maps on chromosome 1p36.1, is contained in the DNA fragment deleted in many NB cell lines bearing MYCN amplification but is conserved in a cell line with a small 1p deletion and normal MYCN. Our observations suggest that retSDR1 is a novel regulator of vitamin A metabolism and that its frequent deletion in NB cells bearing MYCN amplification could compromise the sensitivity of those cells to retinol, thereby contributing to cancer development and progression.
authors.affiliation: Department of Experimental Medicine, University of L'Aquila, Italy.
authors.forename: Fabio
authors.initials: F
authors.lastname: Cerignoli
authors.forename: Xiaojia
authors.initials: X
authors.lastname: Guo
authors.forename: Beatrice
authors.initials: B
authors.lastname: Cardinali
authors.forename: Christian
authors.initials: C
authors.lastname: Rinaldi
authors.forename: Jessica
authors.initials: J
authors.lastname: Casaletto
authors.forename: Luigi
authors.initials: L
authors.lastname: Frati
authors.forename: Isabella
authors.initials: I
authors.lastname: Screpanti
authors.forename: Lorraine J
authors.initials: LJ
authors.lastname: Gudas
authors.forename: Alberto
authors.initials: A
authors.lastname: Gulino
authors.forename: Carol J
authors.initials: CJ
authors.lastname: Thiele
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Giannini
mesh_terms: D000429:Alcohol Oxidoreductases / Q000096:biosynthesis* / Q000235:genetics / Q000378:metabolism; D002878:Chromosomes, Human, Pair 1 / Q000235:genetics; D004790:Enzyme Induction / Q000187:drug effects; D017353:Gene Deletion; D015971:Gene Expression Regulation, Enzymologic; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D009447:Neuroblastoma / Q000201:enzymology* / Q000235:genetics / Q000378:metabolism; D012334:RNA, Neoplasm / Q000235:genetics; D018168:Receptors, Retinoic Acid / Q000378:metabolism; D014212:Tretinoin / Q000494:pharmacology*; D014407:Tumor Cells, Cultured; D014801:Vitamin A / Q000378:metabolism*
chemical_list: D012334:RNA, Neoplasm; D018168:Receptors, Retinoic Acid; D014801:Vitamin A; D014212:Tretinoin; D000429:Alcohol Oxidoreductases; C084155:alcohol dehydrogenase (NAD(P)+)